Teva Women's Health, a US-based subsidiary of Teva Pharmaceutical Industries, has announced FDA acceptance of its Quartette new drug application (NDA). The company is seeking approval to manufacture and market Quartette ...
Tags: ethinyl estradiol tablets, market Quartette, contraceptive products
The US District Court for the Southern District of New York has ruled in favor of Teva Pharmaceutical Industries in Copaxone patent infringement litigation. Teva filed lawsuit against Momenta/Sandoz and Mylan/Natco for infringement of ...
Tags: patent, Teva Pharmaceutical Industries, FDA
Teva Pharmaceutical Industries has entered into a settlement agreement related to Nuvigil patent infringement litigation with Mylan. Under the agreement, Mylan is allowed to sell generic versions of 50mg, 150mg, and 250mg Nuvigil in June ...
Tags: Nuvigil, armodafinil tablets, Teva Pharmaceutical Industries, Mylan
Teva UK, a part of Teva Pharmaceutical Industries, has introduced the generic atorvastatin film-coated tablets in 10mg, 20mg, 40mg and 80mg strengths in the UK. The generic version of Pfizer's Lipitor is indicated for the treatment of ...
Tags: Teva UK, film-coated tablets, treatment of hypercholesterolaemia
Teva Pharmaceutical Industries has introduced an authorized generic of ACTOplus met (pioglitazone/metformin tablets) 15mg/500mg, 15mg/850mg. ACTOplus met is marketed by Takeda Pharmaceuticals USA and used with diet and exercise to improve ...
Tags: Teva Pharmaceutical Industries, pioglitazone tablets, metformin tablets
Teva Pharmaceutical Industries has launched Olanzapine and Fluoxetine Capsules USP 6mg/25mg, 12mg/25mg, 6mg/50mg, and 12mg/50mg. The Olanzapine and Fluoxetine Capsules are the company's generic equivalent to Symbyax. Lilly USA ...
Tags: Teva Pharmaceutical Industries, Olanzapine and Fluoxetine Capsules
Teva Pharmaceutical Industries has unveiled authorized generic of Actos (pioglitazone-hydrochloride tablets) 15mg, 30mg and 45mg in the US. Actos is marketed by Takeda Pharmaceuticals USA and used with diet and exercise to improve blood ...
Teva UK, a part of Teva Pharmaceutical Industries, has announced the launch of generic Ibandronic Acid 150mg film-coated tablets. Ibandronic Acid is a generic version of Bonviva (Ibandronic Acid) from Roche. The product is indicated for ...
Tags: Generic Bonviva, Ibandronic Acid, treatment of osteoporosis
Teva Pharmaceutical Industries has decided not to launch atorvastatin, a generic version of Pfizer's Lipitor. The decision will help Ranbaxy Laboratories and Dr Reddy's Laboratories gain larger sales of the medicine in the US, the ...
Teva Pharmaceutical has received US Food and Drug Administration(FDA)approval for Synribo injection to treat adult patients with chronic phase(CP)or accelerated phase(AP)chronic myeloid leukemia(CML)with resistance and/or intolerance to ...
Tags: Teva Synribo Injection, US FDA, Teva Pharmaceutical, chronic phase
Teva UK, a part of Teva Pharmaceutical Industries, has announced the launch of generic Irbesartan tablets. Irbesartan, a generic version of Aprovel (Irbesartan) by Sanofi Pharma Bristol-Myers Squibb SNC, is indicated to treat essential ...
Tags: Irbesartan Tablets, antihypertensive medicinal product regimen
Teva Pharmaceutical Industries has reported that the Glatiramer Acetate Low-Frequency Administration (GALA) study evaluating a new dose of glatiramer acetate injection (GA) met its primary endpoint. The Phase III trial evaluated the ...
Tags: Teva Pharmaceutical Industries, Medicine, glatiramer acetate injection
Ambit Biosciences and Teva Pharmaceutical Industries have announced the FDA clearance of CEP-32496, a novel BRAF (V600E) kinase inhibitor. The preclinical findings also demonstrate that CEP-32496 possesses potent and sustained anti-tumor ...
Tags: Ambit, Teva, FDA clearance